SoFi Hong Kong Blog - US_MS
Gone Appétit Novo Nordisk’s (NVO) weight management medications Ozempic and Wegovy — intended for people struggling with type 2 diabetes and obesity, respectively — have shot to popularity, not least, because celebrities are open about using them. But these weight-loss drugs might not only reduce waistlines; they could reduce bottom lines, too. As demand for…Read more